Home › Funds › LOWE BROCKENBROUGH & CO INC › AMGN

LOWE BROCKENBROUGH & CO INC position in AMGN

AMGEN INC · Health Care

LOWE BROCKENBROUGH & CO INC reported holding 36,259 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$15.3M, representing 0.66% of its reported portfolio and ranking #43 among its reported holdings. LOWE BROCKENBROUGH & CO INC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)36.26K sh
Reported value held$15.28M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LOWE BROCKENBROUGH & CO INC's AMGN position evolved

LOWE BROCKENBROUGH & CO INC first disclosed a stake in AMGN in Q3 2023 at 36,250 shares (US$9.7M). The position peaked in Q3 2026 at 36,259 shares, worth US$15.3M. Across 13 filings, LOWE BROCKENBROUGH & CO INC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 36,259 shares valued at US$15.3M — an increase of 9,312 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2023 (shares fell 1% over the following quarter), a 36% increase in Q1 2024 (shares rose 10% over the following quarter), a 35% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 36.25K $9.74M New
Q4 2023 25.05K $7.21M Reduce
Q1 2024 34.08K $9.69M Add
Q2 2024 34.03K $10.63M Hold
Q3 2024 24.64K $7.94M Reduce
Q4 2024 24.32K $6.34M Reduce
Q1 2025 24.40K $7.60M Hold
Q2 2025 26.39K $7.37M Add
Q3 2025 27.14K $7.66M Add
Q4 2025 27.26K $8.92M Hold
Q1 2026 27.00K $9.50M Reduce
Q2 2026 26.95K $9.76M Hold
Q3 2026 36.26K $15.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 30 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), VANGUARD CAPITAL MANAGEMENT LLC (US$14.92B), STATE STREET CORP (US$13.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has LOWE BROCKENBROUGH & CO INC held AMGN?

LOWE BROCKENBROUGH & CO INC has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LOWE BROCKENBROUGH & CO INC's current position in AMGN?

As of Q3 2026, LOWE BROCKENBROUGH & CO INC holds 36.26K shares of AMGN (AMGEN INC), valued at $15.28M, representing 0.66% of its reported portfolio and ranking #43.

Has LOWE BROCKENBROUGH & CO INC been buying or selling AMGN?

In the latest 13F filing (Q3 2026), LOWE BROCKENBROUGH & CO INC increased its position in AMGN. The position peaked in Q3 2026 at 36.26K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.